Discover Current and Past Biotech Startups at OGC

Founding member

Developing diagnostic tests for mitochondrial and immune related disorders.

Acquired at OGC

RNA sequencing is vital for cutting-edge cancer diagnostics, pharmaceutical development, and food security, but the time and cost are major bottlenecks.

Series A/B

Over 5,000 different types of gut bacteria analyzed · Largest database of healthy pet microbiome data · Personalized action plans backed by science.

Series A/B

BloodQ develops an analytical platform designed for cancer drug treatment. The company’s platform captures disease molecular signals in circulating DNA to improve sensitivity, specificity, and timing in diagnostic and disease management.

Series A/B

Bristle analyzes the oral microbiome – the makeup of bacteria, fungi, and viruses in saliva – to measure oral health status. Some of these microbes are helpful, and contribute to good oral health while lowering our risk for disease. Other microbes are harmful, directly or indirectly leading to oral and systemic disease.

Aquired at OGC

The Circularis platform provides the ability to rapidly identify context-specific promoters for cell therapy applications, such as those that modulate gene expression in the tumor microenvironment.

Acquired at OGC

Provides software that understands the activity of individual cells as opposed to all cells. This approach is novel because we are no longer looking at average signals and can be precise.

Series A/B

The company’s offerings include harnessing the power of biotechnology by mirroring a natural plant process within microbes to produce colors using completely renewable sources, providing an alternative to make denim.

Immulus

Acquired at OGC

Developer of GMP manufacturing process intended to selectively expand T-cells for drug development.

Series B/C

MycoWorks is a biotechnology company founded by artists with the mission to create a platform for the highest quality materials using Fine Mycelium.

Series A/B

 Cow cheese without the cow. New Culture is making a meltable, stretchable cheese with the mouthfeel of cow-based mozzarella, by employing traditional cheesemaking techniques.

Series A/B

NextGen Jane is a data-driven women’s health company offering a woman insight into her reproductive health through a smart tampon system to track biological changes predictive of disease.

More companies listed below. Join OGC's community of Biotech entrepreneurs

SCHEDULE A CALL OR MEETING IN JUST 30 SECONDS.

Series B/C

Terviva is a food and ag innovation company partnering with farmers to grow pongamia, a climate-resilient tree that helps to reforest land and revitalize communities.

Ali Corp

ASRI is a psychedelics discovery, development, and educational organization dedicated to continuing and extending the work of Dr. Alexander “Sasha” Shulgin.

Avril Biopharma, Inc. uses novel bioinformatics and recombinant gene technologies to design, build and manufacture next-generation molecular medicines.

BrightBox Quantitation manufacturers a proprietary test kit intended for the rapid quantification of DNA or RNA NGS library molecules.

The Circularis platform provides the ability to rapidly identify context-specific promoters for cell therapy applications, such as those that modulate gene expression in the tumor microenvironment.

Delve Therapeutics

Developer of new oncolytic viruses to treat metastatic cancers intended to make viruses tumor-selective without reducing their cancer cell-killing potential.

Gene Friend Way

Jungle Biolabs

Juno Bio

Leap Photovalatics

Lucira Health provides PCR-quality COVID-19 tests for at-home use and enterprise use.

Nextbiotics

October Biosciences’ patent-pending water-soluble formula absorbs more readily than most other CBD products in the market, absorbed at a whopping 80%.

Phylos is the first modern crop science company using molecular genetics and computational biology to breed the next generation of hemp and cannabis.

Public Health

Purple City Genetics is a cannabis collective producing exceptional seed and clone stock for the best cultivators in the world.

Reservoir Neuroscience is developing the world’s first therapeutics to heal the blood-brain barrier.

Rev Genomics creates high-value crop cultivars that contain valuable biochemicals.

Reservoir Neuroscience is developing the world’s first therapeutics to heal the blood-brain barrier.

Root Applied Sciences is bringing agriculture into the future with airborne pathogen monitoring for precision crop management.

Sugarlogix is creating prebiotic sugars with functional benefits for your gut health.

Energy solutions that meet the needs of both people and the planet.